Bill Belichick’s first season at North Carolina was always going to be scrutinized, but not just for football reasons. The six-time Super Bowl winning coach arrived in Chapel Hill with unmatched ...

In a decade, Eli Lilly could be in the same place that Pfizer finds itself in today. The big story around Eli Lilly is the success of its GLP-1 drugs Mounjaro (for diabetes) and Zepbound (for weight ...

Eli Lilly's decision to reduce the price of its popular weight loss drug makes more sense than it appears at first. The company still has a robust business that is delivering excellent results and ...

Eli Lilly LLY-0.45%decrease; red down pointing triangle plans to build a $6 billion facility in Huntsville, Ala., to make active pharmaceutical ingredients, including those used in weight-loss drugs.

Eli Lilly’s next-generation obesity treatment may prove highly effective for patients who have high BMI or suffer from obesity-related complications. The company has a diversified portfolio across ...

SHANGHAI, Dec 8 (Reuters) - Eli Lilly's (LLY.N), opens new tab popular drug Mounjaro will be added to China's state-run health insurance scheme from January 1 for patients with type 2 diabetes, the ...

Chris Anderson once told Deirdre Virvo that he wouldn’t do business with a man who cheated on his wife. A cheat at home would cheat at work, he said. In the five years she’d known him, worked with him ...

Ole Miss legend Eli Manning couldn’t help but respond to new LSU head coach Lane Kiffin’s claim that Rebels fans tried to run him off the road as he left ...

Dec 9 (Reuters) - Eli Lilly (LLY.N), opens new tab said on Tuesday it will invest more than $6 billion in a new active drug ingredient manufacturing facility in Huntsville, Alabama, to expand U.S.

The details of Eli Drinkwitz’s new deal are official. Missouri athletic director Laird Veatch met with local media Monday evening to discuss the details of Drinkwitz’s contract extension, which is, as ...

After nearly a decade of steady payout, New York’s largest office landlord could lower its dividend next year as earnings fall. SL Green, developer of 1 Vanderbilt Ave., has paid out about $3 a share ...

Eli Lilly has surpassed analysts’ highest hopes for the efficacy of retatrutide, linking the triple agonist to 28.7% weight loss and a 75.8% reduction in pain scores in patients with obesity and knee ...